Previous Article | Next Article ![]()
Journal of Virology, July 1999, p. 5748-5756, Vol. 73, No. 7
Department of Molecular Biology, Princeton
University, Princeton, New Jersey 08544
Received 28 February 1999/Accepted 15 April 1999
After pseudorabies virus (PRV) infection of murine L929 cells, the
cell surface expression of major histocompatibility complex (MHC) class
I proteins changes such that the total amount of MHC class I molecules
remains relatively constant but the levels of the individual alleles
Dk and Kk vary. This is an active process
involving at least three PRV gene products that act in an
allele-specific manner such that cell surface expression of MHC class I
Dk is decreased and that of Kk is increased.
Our results indicate that an early gene product mediates the overall
reduction in Dk protein and a late gene product which is
mutant in the attenuated PRV strain Bartha mediates the increase in
Kk protein. We provide additional evidence for a third gene
product involved in the regulation of the synthesis of both the
Dk and Kk proteins. In addition, we show that
the early decrease in the Dk protein is not due to a block
in synthesis or processing of the complex through the secretory system.
Pseudorabies virus (PRV) is a
pathogen of swine and cattle (25). PRV is a member of the
alphaherpesvirus family that includes the human pathogens herpes
simplex virus (HSV) and varicella-zoster virus. Like many of the
viruses in this family, PRV has the capacity to invade the local
peripheral nervous system, where it establishes a latent infection that
can be reactivated. Primary infection of older pigs often results in a
mild respiratory disease with the virus establishing a latent infection
in sensory ganglia innervating nasopharyngeal surfaces. In contrast,
primary PRV infection of young pigs often results in lethal
encephalitis with the virus invading the spinal cord and brain. PRV
also infects a wide variety of mammals and some birds, and invariably,
primary infection of these animals results in fatal encephalitis
(9).
In order to establish a primary infection and be maintained in the host
population, the alphaherpesviruses must be able to evade both innate
and acquired immune defenses with some efficiency. The ability of PRV
to establish primary, acute, lethal brain infections in diverse hosts
suggests that general innate defenses are easily overcome by this
virus. Little is known about the molecular mechanisms involved in this
process. During a primary PRV infection, infected cells are first
recognized by the innate immune system comprising, in part, natural
killer (NK) cells, complement, and the interferons. Action by these
innate defenses is presumed to limit spread and confine the infection
to local mucosal surfaces. It is known that NK cells contribute to the
nonspecific clearance of virally infected cells after primary virus
infection. Depletion of NK cells from mice before PRV infection results
in higher virus titers in the brain and reduced survival. Conversely,
when NK cell activity is stimulated by addition of serum thymic factor,
virus titers are reduced with a concomitant increase in animal survival
(27). Interestingly, in vitro assays have shown that some
PRV-infected cell types are sensitive to NK cell-mediated lysis while
other cell types are resistant (6, 18). The mechanisms by
which NK cells recognize infected cells are under study in many
laboratories, but one idea is that cells with reduced levels of major
histocompatibility complex (MHC) class I proteins on the cell surface
are preferentially attacked by NK cells (16).
If an animal survives PRV infection, the virus is invariably found
latent in sensory and autonomic ganglia innervating the tissue where
the primary infection occurred (9). Such latently infected
animals are immunized and have circulating antibody and cytotoxic T
cells (CTLs) that can react with PRV-infected cells (24).
When the latent infection reactivates in these immunized animals,
infected cells would be recognized by these CTLs through T-cell
receptor binding to specific intracellularly derived viral peptides
bound to cell surface MHC class I proteins. In this case, action of
CTLs would limit local spread of infection and promote clearance of the
virus and virus-infected cells.
It is clear that the MHC class I proteins represent a key host defense
interface that is critical for both innate and acquired immune
defenses. Therefore, as might be expected, MHC class I protein
expression is regulated by many viruses. In particular, many
herpesviruses encode proteins that modulate MHC class I levels in
infected cells (2, 4, 7, 14, 17, 23, 26, 30, 38). Such
proteins act at several points in the MHC class I peptide presentation
pathway, including transcription, intracellular peptide processing and
loading, MHC class I protein stability, and passage through the
secretory system to the final destination on the cell surface
(12).
In this report, we present evidence for differential regulation of
specific classes of MHC class I proteins on the cell surface after
primary infection of murine cells by PRV. Despite differential appearance of MHC class I proteins, the total concentration remains relatively unchanged after viral infection. We show that an early PRV
gene product initially reduces the cell surface concentration by
destabilizing cell surface molecules, not by interfering with the
synthesis or processing of the MHC class I complex. Late in infection,
a second PRV gene product reduces the synthesis of both Dk
and Kk without further reducing cell surface levels of MHC
class I. We also show that the PRV gene product that increases
Kk levels is a late gene product and is mutant in the
attenuated PRV strain Bartha, suggesting that regulation of MHC I is
one factor in the virulence of this virus. While the biological
significance of these observations is currently under study, we
speculate that by affecting the specific composition of MHC class I
molecules on the surface of an infected cell, PRV may evade both NK-
and T-cell-mediated responses.
Cells, viruses, and antibodies.
PK15 (swine kidney) cells
were maintained in Dulbecco modified Eagle medium plus 10% fetal
bovine serum (FBS). L929 (mouse fibroblast) cells (American Type Tissue
Collection, Manassas, Va.) were maintained in minimal essential medium
plus 10% FBS. All PRV strains were grown in PK15 cells in Dulbecco
modified Eagle medium plus 2% FBS. The antibodies used are described
in Table 1.
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Differential Regulation of Dk and Kk
Major Histocompatibility Complex Class I Proteins on the Cell Surface
after Infection of Murine Cells by Pseudorabies Virus
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
TABLE 1.
Antibodies used in this study
Inactivation of viral particles.
-Propiolactone (0.08%;
Sigma) was added to PRV strain Becker, and the mixture was incubated
for 30 min on ice. The stock was then incubated at 37°C for 4 h
and then returned to 4°C for 72 h. The resulting precipitate was
then removed by centrifugation. The titer of the resulting stock was
determined on PK15 cells.
Fluorescence-activated cell sorter (FACS) analysis. Cells were infected with a multiplicity of infection (MOI) of 10 in minimal essential medium plus 2% FBS and incubated for 14 to 16 h. Cells (106) were then trypsinized briefly, resuspended in phosphate-buffered saline-3% bovine serum albumin (BSA) with the appropriate primary antibody, and incubated on ice for 30 min. Cells were then resuspended in the appropriate secondary antibody diluted in phosphate-buffered saline plus 3% BSA and incubated for 30 min on ice. The stained cells were then fixed in 1% formaldehyde, and 10,000 cells were analyzed by flow cytometry (FACScan; Becton Dickinson).
Phosphonoacetic acid (PAA) experiments. Cells were pretreated for 1 h in the presence of PAA (400 µg/ml; Sigma) and then infected with PRV strain Becker in the presence of PAA for 16 h. Cells were then analyzed by flow cytometry as described above.
Citrate wash experiments. L929 cells were infected and then washed with citrate wash (0.062 M Na2HPO4, 0.132 M citric acid, 0.5% BSA, pH 3) for 2 min at 4 or 8 h postinfection as described by Sugawara et al. (34). The citrate wash was then neutralized by being washed three times with medium. Cells were then incubated in fresh medium at 37°C and analyzed by flow cytometry as described above at 24 h postinfection. For the cycloheximide experiment, cells were treated with citrate wash and then washed as described above. Cycloheximide was then added (500 µg/ml). The cells were harvested at 6 h postwash.
| |
RESULTS |
|---|
|
|
|---|
PRV infection has little effect on the overall cell surface
expression of MHC class I.
We determined whether the overall cell
surface expression of MHC class I was changed in PRV-infected mouse
fibroblast (L929) cells. Cells were infected with PRV strain Becker at
an MOI of 10 for 16 h and then stained for FACS analysis as
described in Materials and Methods. All cells were infected, as shown
by expression of the viral glycoprotein gB (Fig.
1C). We used an antibody that recognizes
two alleles of MHC class I found on the surface of these cells
(Dk and Kk), as well as an antibody against
2-microglobulin which recognizes all MHC class I species.
Comparisons of MHC class I concentrations on the surface of these cells
showed a slight decrease in both
2-microglobulin and total
Dk and Kk expression after PRV infection (Fig.
1A and B). These results show that there is no significant change in
overall MHC class I expression on the surface of these cells after PRV
infection.
|
The cell surface concentration of two MHC class I alleles changes after PRV infection. Since previous studies had indicated that MHC class I was reduced in PRV-infected cells (23), we next examined the cell surface expression of specific MHC class I alleles Dk and Kk on infected L929 cells. As shown in Fig. 2B, all cells were infected, as demonstrated by robust expression of the viral glycoprotein gB. After infection, cell surface expression of Dk was reduced by approximately 70% (Fig. 2A). In contrast to the results shown by Mellencamp et al. (23), we found that cell surface expression of Kk was increased by 130% (Fig. 2C, D, and E) by using three separate monoclonal antibodies to Kk (16-3-1N, 11-4.1, and AF3-12.1.S). Similar results were obtained when cells were infected with three different strains of PRV, i.e., Phylaxia, Kaplan, and NIA-3 (data not shown). We conclude that PRV infection modulates the steady-state concentration of MHC class I proteins on the cell surface of murine fibroblast cells such that at late times after infection, the Dk protein is reduced while the Kk protein is increased.
|
Both early and late viral gene products affect cell surface expression of MHC class I proteins. We next determined if early or late PRV gene products affected cell surface expression of MHC class I proteins. To do so, we relied on the fact that viral late gene expression requires DNA replication, while early gene expression can occur from nonreplicated genomes. By adding PAA, an inhibitor of viral DNA replication, to the cells during infection, late gene expression is prevented, but early genes are still expressed (25).
L929 cells were pretreated with PAA at 400 µg/ml for 1 h prior to infection and then infected with PRV strain Becker at an MOI of 10 in the presence of PAA for 16 h. Cells were then stained for MHC class I proteins and analyzed as previously described, except that the late viral glycoprotein gC was used to control for infectivity. As predicted, gC expression was reduced more than 350% after addition of PAA compared to that on untreated cells (compare Fig. 3C with Fig. 3F). In the absence of PAA, Dk was reduced by 44% and Kk was increased by 50% (Fig. 3A and B). In the presence of PAA, Dk surface expression decreased by 60% but Kk expression increased by only 15% compared to that on mock-infected, PAA-treated cells (Fig. 3D and E). Clearly, the addition of PAA had no effect on the reduction of Dk. This observation suggests that an early gene product(s) is involved in this phenomenon. On the other hand, the addition of PAA effectively blocked the increased expression of Kk. This suggests that a late gene product(s) is involved in this process. These experiments provide additional evidence that PRV can regulate MHC class I in an allele-specific manner since the gene product responsible for the phenomenon can be separated into two different kinetic classes.
|
-propiolactone as described in Materials and Methods. This
reduced the viral titer to less than 50 PFU/ml (data not shown). We
then infected cells at an MOI of 10 as determined before inactivation
and compared the amounts of reduction of Dk obtained with
inactivated and infectious virus. Cells infected with inactivated virus
did not reduce cell surface levels of MHC class I, in contrast to cells
infected with infectious virus (Fig. 3G). As expected, cells infected
with inactivated virus also did not increase Kk levels
(Fig. 3H) or express the viral gB protein (Fig. 3I). Therefore, it is
unlikely that a late gene product which is a structural component of
the virion is involved in MHC class I regulation.
Cell surface expression of MHC class I alleles after infection by the attenuated Bartha strain of PRV. In an initial attempt to map the gene products involved in regulating cell surface expression of MHC class I proteins, we infected L929 cells with the attenuated Bartha strain of PRV. This strain harbors a number of known mutations, including a deletion in the Us region, which encompasses gI, gE, Us9, and Us2, and point mutations in gC, UL21, and gM (8, 20, 21, 32). Comparison of infections of L929 cells with PRV strains Becker and Bartha provided further evidence that different gene products mediate allele-specific MHC class I protein accumulation on the surface of infected cells. Both viruses caused a marked 60% reduction in MHC class I Dk protein on the surface of infected cells (Fig. 4A and D). In contrast, PRV strain Bartha-infected cells showed little or no sign of increased expression of MHC class I Kk (Fig. 4E). The amount of this allele increased by only 15% after infection with PRV strain Bartha, compared to the 70% increase obtained with PRV strain Becker in this experiment (Fig. 4B). All cells were infected, as shown by gB expression (Fig. 4C and F). Thus, PRV strain Bartha is defective in the gene product(s) responsible for increasing Kk on the cell surface.
|
Early decrease in MHC Dk protein on L929 cells is not
due to blocked synthesis or processing of the molecule.
We next
determined if PRV infection affects the synthesis or posttranslational
processing of the MHC class I proteins. More specifically, we
determined if the lack of Dk on the cell surface after
infection resulted because MHC heavy chains were no longer synthesized
or were blocked in the assembly of the MHC class
I-peptide-
2-microglobulin complex or its transport through the
secretory system to the cell surface. Previously, Sugawara et al.
(34) have shown that treatment of cells by washing with pH 3 citrate buffer removes all detectable MHC class I protein from the cell
surface. If a neutral pH is restored, newly synthesized MHC class I
molecules quickly repopulate the cell surface. Thus, we can determine
if the block in Dk cell surface expression after PRV
infection is due to blocked synthesis of the molecule or its transport
to the cell surface or if it is due to an alteration in the cell
surface stability of the molecule. Eighty percent of the cell surface
MHC class I protein is removed by citrate washing of uninfected cells,
as shown in Fig. 5A and D. The expression
of all cell surface proteins was not affected by citrate washing, as gB
expression was not affected by citrate washing (Fig.
6I). In addition, Sugawara et al.
(34) have shown that MHC class II protein is not affected by
citrate washing. If the cells are then allowed to recover in fresh
medium for 6 h, MHC class I protein returns to the cells surface
to the same level as before washing (Fig. 5B and E).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
After PRV infection of murine L929 cells, the cell surface expression of MHC class I proteins changes such that the total amount remains relatively constant but the amounts of the Dk and Kk alleles vary. This is an active process involving at least three PRV gene products which act in an allele-specific manner such that MHC class I Dk is decreased and Kk is increased. Our results indicate that an early gene product which is functional in the attenuated PRV strain Bartha mediates the overall reduction of Dk and a late gene product which is defective in PRV strain Bartha mediates the increase in Kk. We provide additional evidence for a third gene product which reduces the synthesis of both the Dk and Kk proteins. In addition, we show that the early decrease in Dk is not due to blocking the synthesis of MHC class I or of transport of the complex through the secretory system.
Our results directly contradict those of Mellencamp et al. (23), who showed that the intracellular and cell surface concentrations of both the Kk and Dk proteins were reduced after PRV infection. We cannot explain this discrepancy. We have confirmed our results by using three different antibodies against Kk, including AF3-12.1.S, the antibody used by Mellencamp et al. While some experiment-to-experiment variability exists, we have never observed the cell surface concentration of the Kk protein to be less than that found on mock-infected cells, even at early points during infection. We have not used the same viral strain used by Mellencamp et al. (the Indiana Funkhauser strain), but we have confirmed our results with four different PRV strains (Becker, NIA-3, Kaplan, and Phylaxia). It appears unlikely that strain differences are responsible for the difference between our results. One possible difference in our experiments could be the medium and serum in which the cells were grown, as these variables are known to affect MHC class I protein expression (data not shown). Unfortunately, Mellencamp et al. did not state the growth conditions used in their experiments, and we cannot reproduce their experimental protocol precisely.
The viral genes involved in MHC class I regulation remain to be identified. PRV does not contain easily identifiable homologs to the gene products of other herpesviruses known to affect cell MHC class I protein expression. However, after using the viral DNA synthesis inhibitor PAA, we suggest that an early PRV gene product is involved in reduction of the cell surface concentration of the MHC class I Dk protein. It is also possible that the immediate-early protein IE180 or a structural component of the virion which is synthesized late in infection is responsible. To test the first idea, we transfected a plasmid expressing the IE180 protein into PK15 cells and observed a marked increase and not a decrease in the amount of MHC class I protein on the cell surface (data not shown). This most likely reflects the promiscuous transcriptional activator activity of this protein. The simple idea that the IE180 protein reduces MHC class I expression cannot be correct. We tested the second idea by using inactivated virus preparations and found that these preparations did not reduce the cell surface levels of Dk. Thus, viral structural proteins which are synthesized late in infection are unlikely to be involved in this phenomenon.
The citrate wash experiments provided evidence that a late viral gene product is required to block the synthesis or transport of both the Dk and Kk proteins. One candidate protein is the virion host shutoff (vhs) homolog encoded by the UL41 gene that is known to reduce the synthesis of many host proteins after HSV type 1 infection, including MHC class I proteins (31, 36). Host protein synthesis is reduced in PRV-infected cells, but it is not clear that the PRV UL41 homolog is responsible for this effect. In L929 cells, host protein synthesis is virtually unchanged at 4 h postinfection but is markedly reduced by 8 h postinfection (data not shown). This observation is consistent with the kinetics of MHC class I shutoff, as demonstrated by the citrate wash experiments. Alternatively, PRV may encode a second gene that specifically reduces the synthesis or transport of both MHC class I alleles through the secretory system.
The attenuated PRV strain Bartha is defective in the expression or action of the late gene product that increases cell surface expression of the Kk protein. We have attempted to identify this Bartha mutation by infecting L929 cells with recombinant PRV strain Becker containing some of the individual known mutations in strain Bartha. Such viruses included a strain Becker recombinant expressing the strain Bartha gC-encoding gene and Becker viruses with the genes for gE, gI, and Us9 deleted. We have not been able to identify the Bartha mutation by this approach. Since PRV strain Bartha has not been completely sequenced, we cannot conclude that the mutation maps to gM, Ul21, or Us2, as other, unidentified, mutations may be involved.
We have ruled out several mechanisms that might be responsible for the early decrease in Dk on the cell surface by using low-pH citrate washes to remove MHC class I proteins from the surface of cells at different points during infection. First, we have demonstrated that MHC class I proteins can be synthesized and transported through the secretory system to the cell surface at early times postinfection when the initial MHC class I decrease is seen. Thus, PRV does not reduce cell surface expression of MHC class I proteins by interfering with transcription of the MHC class I heavy chain or by retaining the complex in the endoplasmic reticulum (ER), as has been found for other viruses (12). Second, the citrate wash results might reflect reduced stability of the MHC class I complex on the surface of infected cells. In this case, PRV infection might interfere with peptide binding to MHC class I heavy-chain complexes, as has been shown to occur for both HSV and human cytomegalovirus (CMV) (12). It is known that MHC class I heavy chains exhibit reduced stability when they are on the cell surface without peptide. As a result, differential appearance of MHC class I proteins may reflect the stabilities of specific MHC class I proteins when no longer complexed with peptide (1). In this regard, previous studies have shown that Kk molecules are particularly stable in the absence of peptide (35). Thus, despite interference with peptide transport into the ER, Kk molecules without peptides would still be present on the cell surface in relatively normal amounts. The increased stability of Kk molecules with no peptide over Dk proteins with no peptide would result in apparent allele-specific regulation of MHC class I appearance on the cell surface.
Cell surface expression of MHC class I Kk protein increased late in infection, despite an apparent decrease in intracellular synthesis (Fig. 2B, C, and D and 6F). This finding may reflect two independent mechanisms affecting the localization of the Kk protein. First, we believe that the Kk protein can be transported to the cell surface in the absence of protein synthesis because the Kk protein returns to the surface after citrate washing in the presence of cycloheximide (Fig. 5E). Second, from experiments done by Tirabassi et al. (37), we know that PRV infection blocks internalization of viral proteins from the plasma membrane after 6 h of infection. If PRV infection promotes a general inhibition of endocytosis late after infection, then proteins on the cell surface would be stabilized and a synthesis block would not be detectable by examination of cell surface molecules. This idea is consistent with our observations of Dk expression throughout infection. Cell surface expression of Dk falls to approximately 70% of the levels in mock-infected cells by 4 h postinfection yet stays at this level even though synthesis of Dk is decreased. The concentration of Dk protein may be stabilized at the cell surface late in infection because it cannot be internalized and turned over. Since Kk molecules would continue to be transported to the cell surface in the absence of any new synthesis, more Kk than Dk protein would be seen after endocytosis was inhibited.
Differential regulation of MHC class I proteins is not unique to PRV
infection and has been demonstrated after infection with both RNA and
DNA viruses. For example, mouse hepatitis virus (a coronavirus)
infection results in increased expression of the Dd allele
and a decrease in the Kd allele in murine cerebral
endothelial cells (15). The adenovirus E3 19K protein binds
more tightly to some human MHC class I alleles than to others, which
results in a small fraction of the Aw68, B27, and Bw58 alleles escaping
intracellular retention (3). The Us11 and Us2 proteins of
human CMV bind to specific mouse MHC class I proteins and cause their
degradation by dislocating the newly synthesized heavy chains from the
ER into the cytoplasm. Us11 binds to Kb, Dd,
Db, and Ld, whereas Us2 only binds to
Dd and Db (22). In addition, HSV has
been shown to differentially affect the association of MHC heavy chains
with
2-microglobulin such that the B51 allele does not associate
with
2-microglobulin in HSV-infected human fibroblast cells while
the A29 allele assembles normally with both
2-microglobulin and
peptide. Neither allele becomes normally sialylated; this is a
characteristic of MHC class I heavy chains reaching the cell surface
(13). We have also found that in PRV-infected swine kidney
(PK15) cells, MHC class I proteins recognized by different monoclonal
antibodies are differentially expressed, such that one MHC class I
protein is decreased early in infection and one MHC class I protein is
decreased late in infection (unpublished results).
A general reduction in the amount of MHC class I protein on the surface of PRV-infected cells may help the virus to evade detection by circulating T cells and thus allow the virus to cause disease in the central nervous system. There is some data to support this notion. An HSV type 1 mutant defective in the ICP47-encoding gene, the gene responsible for reduced cell surface expression of MHC class I, is less virulent presumably because CD8+ T cells are able to limit the infection (11). However, by reducing overall cell surface levels of MHC class I protein, virally infected cells would become more sensitive to NK cell-mediated lysis (16). By lowering the concentration of some, but not all, MHC class I proteins on the cell surface, PRV-infected cells may escape detection by NK cells. In fact, it is known that NK cell-mediated cell lysis is not increased during PRV infection in some cell types (5; data not shown). The ability to evade NK cell recognition is critical in murine CMV infection, in which a mutant with a change in the MHC class I homolog-encoding gene (m144) exhibits restricted replication in mice containing NK cells but replicates normally in mice depleted of NK cells (10). Thus, although murine CMV decreases cell surface levels of MHC class I protein by a variety of mechanisms, a second gene product that mimics MHC class I protein is required to evade NK cells for a productive infection to occur.
In summary, we have presented evidence that PRV infection affects the steady-state concentration of MHC class I proteins on the cell surface in a differential fashion. The concentration of the MHC class I Kk protein increases after infection, while the MHC class I Dk protein decreases after infection. In addition, at least three PRV gene products may be involved in this phenomenon. The biological implications of these findings in animal infections are not known. However, we speculate that the ability to alter the composition of specific MHC class I molecules on the surface of an infected cell might enable the virus to evade both NK- and T-cell-mediated responses after primary infection and reactivation from latency.
| |
ACKNOWLEDGMENTS |
|---|
We thank Albert Bendelac, Hidde Ploegh, H.-J. Rziha, and Armin Saalmüller for helpful discussions; Albert Bendelac and Hidde Ploegh for antibodies; Andrew Beavis for help with the FACScan; and all members of the Enquist lab for their help and support.
R.L.S.-T. is supported by NIH training grant 5T32GM07388. This work was supported by grant 1R0133506NDS and NATO Collaborative Research Grant CRG 951341 to L.W.E.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Molecular Biology, Princeton University, Princeton, NJ 08544. Phone: (609) 258-2415. Fax: (609) 258-1035. E-mail: Lenquist{at}molbiol.princeton.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Baas, E. J.,
H.-M. van Santen,
M. J. Kleijmeer,
H. J. Geuze,
P. J. Peters, and H. L. Ploegh.
1992.
Peptide-induced stabilization and intracellular localization of empty HLA class I complexes.
J. Exp. Med.
176:147-156 |
| 2. | Beersma, M. F. C., M. O. Bijlmakers, and H. L. Ploegh. 1993. Human cytomegalovirus down-regulates HLA class I expression by reducing the stability of class I H chains. J. Immunol. 151:4455-4464[Abstract]. |
| 3. | Beier, D. C., J. H. Cox, D. R. Vining, P. Cresswell, and V. H. Engelhard. 1994. Association of human class I MHC alleles with the adenovirus E3/19K protein. J. Immunol. 152:3862-3872[Abstract]. |
| 4. |
Campbell, A. E., and J. S. Slater.
1994.
Down-regulation of major histocompatibility complex class I synthesis by murine cytomegalovirus early gene expression.
J. Virol.
68:1805-1811 |
| 5. | Chinsakchai, S., and T. W. Molitor. 1994. Immunobiology of pseudorabies virus infection in swine. Vet. Immunol. Immunopathol. 43:107-116[Medline]. |
| 6. | Chinsakchai, S., and T. W. Molitor. 1992. Replication and immunosuppressive effects of pseudorabies virus on swine peripheral blood mononuclear cells. Vet. Immunol. Immunopathol. 30:247-260[Medline]. |
| 7. | Cohen, J. I. 1998. Infection of cells with varicella-zoster virus down-regulates surface expression of class I major histocompatibility complex antigens. J. Infect. Dis. 155:1390-1393. |
| 8. | Dijkstra, J. M., T. C. Mettenleiter, and B. G. Klupp. 1997. Intracellular processing of pseudorabies virus glycoprotein M (gM): gM of strain Bartha lacks N-glycosylation. Virology 237:113-122[Medline]. |
| 9. | Enquist, L. W., P. J. Husak, B. W. Banfield, and G. A. Smith. 1998. Infection and spread of alphaherpesviruses in the nervous system. Adv. Virus Res. 51:237-347[Medline]. |
| 10. | Farell, H. E., H. Vally, D. M. Lynch, P. Fleming, G. R. Shellam, A. A. Scalzo, and N. J. Davis-Poynter. 1997. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature 386:510-514[Medline]. |
| 11. |
Goldsmith, K.,
W. Chen,
D. C. Johnson, and R. L. Hendricks.
1998.
Infected cell protein (ICP) 47 enhances herpes simplex virus neurovirulence by blocking the CD8+ T cell response.
J. Exp. Med.
187:341-348 |
| 12. | Hengel, H., and U. H. Koszinowski. 1997. Interference with antigen processing by viruses. Curr. Opin. Immunol. 9:470-476[Medline]. |
| 13. | Hill, A. B., B. C. Barnett, A. J. McMichael, and D. J. McGeogh. 1994. HLA class I molecules are not transported to the cell surface in cells infected with herpes simplex virus types 1 and 2. J. Immunol. 152:2736-2741[Abstract]. |
| 14. |
Jennings, S. R.,
P. L. Rice,
E. D. Kloszewski,
R. W. Anderson,
D. L. Thompson, and S. S. Tevethia.
1985.
Effect of herpes simplex virus types 1 and 2 on surface expression of class I major histocompatibility complex antigens on infected cells.
J. Virol.
56:757-766 |
| 15. | Joseph, J., R. L. Knobler, F. D. Lublin, and M. N. Hart. 1989. Differential modulation of MHC class I antigen expression on mouse brain endothelial cells by MHV-4 infection. J. Neuroimmunol. 22:241-253[Medline]. |
| 16. | Kärre, K. 1993. Natural killer cells and the MHC class I pathway of peptide presentation. Semin. Immunol. 5:127-145[Medline]. |
| 17. | Kimman, T. G., A. T. J. Bianchi, T. G. M. de Bruin, W. A. M. Mulder, J. Priem, and J. M. Voermans. 1995. Interaction of pseudorabies virus with immortalized porcine B cells: influence on surface class I and II major histocompatibility and immunoglobulin M expression. Vet. Immunol. Immunopathol. 45:253-263[Medline]. |
| 18. | Kimman, T. G., T. G. M. D. Bruin, J. J. M. Voermans, and A. T. J. Bianchi. 1996. Cell-mediated immunity to pseudorabies virus: cytolytic effector cells with characteristics of lymphokine-activated killer cells lyse virus-infected glycoprotein gB- and gC-transfected L14 cells. J. Gen. Virol. 77:978-990. |
| 19. | Loken, M. R., and A. M. Stall. 1982. Flow cytometry as an analytical and preparative tool in immunology. J. Immunol. Methods 50:R85-R112[Medline]. |
| 20. |
Lomniczi, B.,
S. Watanabe,
T. Ben-Porat, and A. S. Kaplan.
1984.
Genetic basis of the neurovirulence of pseudorabies virus.
J. Virol.
52:198-205 |
| 21. |
Lomniczi, B.,
S. Watanabe,
T. Ben-Porat, and A. S. Kaplan.
1987.
Genome location and identification of functions defective in the Bartha vaccine strain of pseudorabies virus.
J. Virol.
61:796-801 |
| 22. |
Machold, R. P.,
E. J. H. J. Wiertz,
T. R. Jones, and H. L. Ploegh.
1997.
The HCMV gene products US11 and US2 differ in their ability to attack allelic forms of murine major histocompatibility complex (MHC) class I heavy chains.
J. Exp. Med.
185:363-366 |
| 23. |
Mellencamp, M. W.,
P. C. M. O'Brien, and J. R. Stevenson.
1991.
Pseudorabies virus-induced suppression of major histocompatibility complex class I antigen expression.
J. Virol.
65:3365-3368 |
| 24. | Mettenleiter, T. C. 1996. Immunobiology of pseudorabies virus (Aujesky's disease). Vet. Immunol. Immunopathol. 54:221-229[Medline]. |
| 25. | Mettenleiter, T. C. 1994. Pseudorabies virus (Aujesky's disease): state of the art. Acta Vet. Hung. 42:153-177[Medline]. |
| 26. | Nataraj, C., S. Eidmann, M. J. Hariharan, J. H. Sur, G. A. Perry, and S. Srikumaran. 1997. Bovine herpesvirus 1 downregulates the expression of bovine MHC class I molecules. Viral Immunol. 10:21-34[Medline]. |
| 27. | Onodera, T., K. Yoshihara, T. Suzuki, T. Tsuda, T. Ikeda, A. Aawaya, H. Kobayashi, and M. Yukawa. 1994. Resistance to pseudorabies virus with enhanced interferon production and natural killer cell activity in mice treated with serum thymic factor. Microbiol. Immunol. 38:47-53[Medline]. |
| 28. | Ozato, K., P. Henkart, J. Cornelius, and D. Sachs. 1981. Spatially distinct allodeterminants of the H-2Kk molecule as detected by monoclonal anti-H-2 antibodies. J. Immunol. 126:1780-1785[Abstract]. |
| 29. | Ozato, K., N. Mayer, and D. H. Sachs. 1980. Hybridoma cell lines secreting monoclonal antigens to mouse H-2 and Ia antigens. J. Immunol. 124:533-540[Abstract]. |
| 30. |
Pereira, R.,
D. C. Tscharke, and A. Simmons.
1994.
Upregulation of class I major histocompatibility complex gene expression in primary sensory neurons, satellite cells and Schwann cells of mice in response to acute but not latent herpes simplex virus infection in vivo.
J. Exp. Med.
180:841-850 |
| 31. | Read, G. S. 1997. Control of mRNA stability during herpes simplex virus infections, p. 311-321. In J. B. Hartford, and D. R. Morris (ed.), mRNA metabolism and post-transcriptional gene regulation. Wiley-Liss, New York, N.Y. |
| 32. |
Robbins, A. K.,
J. P. Ryan,
M. E. Whealy, and L. W. Enquist.
1989.
The gene encoding the gIII envelope protein of pseudorabies virus vaccine strain Bartha contains a mutation affecting protein localization.
J. Virol.
63:250-258 |
| 33. |
Ryan, J. P.,
M. E. Whealy,
A. K. Robbins, and L. W. Enquist.
1987.
Analysis of pseudorabies virus glycoprotein gIII localization and modification by using novel infectious viral mutants carrying unique EcoRI sites.
J. Virol.
61:2962-2972 |
| 34. | Sugawara, S., T. Abo, and K. Kumagai. 1987. A simple method to eliminate the antigenicity of surface class I MHC molecules from the membrane of viable cells by acid treatment at pH 3. J. Immunol. Methods 100:83-90[Medline]. |
| 35. | Tan, L., M. H. Andersen, T. Elliot, and J. S. Haurum. 1997. An improved assembly assay for peptide binding to HLA-B*2705 and H-2Kk class I MHC molecules. J. Immunol. Methods 209:25-36[Medline]. |
| 36. |
Tigges, M. A.,
S. Leng,
D. C. Johnson, and R. L. Burke.
1996.
Human herpes simplex virus (HSV)-specific CD8+ CTL clones recognize HSV-2-infected fibroblasts after treatment with INF- or when virion host shutoff functions are disabled.
J. Immunol.
156:3901-3910[Abstract].
|
| 37. | Tirabassi, R. S., R. A. Townley, M. G. Eldridge, and L. W. Enquist. 1997. Characterization of pseudorabies virus mutants expressing carboxy-terminal truncations of gE: evidence for envelope incorporation, virulence, and neurotropism domains. J. Virol. 71:6455-6464[Abstract]. |
| 38. |
Zeildler, R.,
G. Eissner,
P. Meissner,
S. Uebel,
R. Tampe,
S. Lazis, and W. Hammerschmidt.
1997.
Downregulation of TAP1 in B lymphocytes by cellular and Epstein-Barr virus-encoded interleukin-10.
Blood
90:2390-2397 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»